Blue Jet Healthcare Limited (BLUEJET) - Total Assets
Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) holds total assets worth Rs16.41 Billion INR (≈ $177.49 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check BLUEJET capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Blue Jet Healthcare Limited - Total Assets Trend (2020–2026)
This chart illustrates how Blue Jet Healthcare Limited's total assets have evolved over time, based on quarterly financial data. Check cash flow quality index of Blue Jet Healthcare Limited to evaluate the quality of earnings relative to operating cash generation.
Blue Jet Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Blue Jet Healthcare Limited's total assets of Rs16.41 Billion consist of 58.3% current assets and 41.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 9.1% |
| Accounts Receivable | Rs3.39 Billion | 20.7% |
| Inventory | Rs1.87 Billion | 11.4% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs21.75 Million | 0.1% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2020–2026)
This chart illustrates how Blue Jet Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Blue Jet Healthcare Limited market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Blue Jet Healthcare Limited's current assets represent 58.3% of total assets in 2026, a decrease from 66.3% in 2020.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2026, up from 2.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 20.7% of total assets.
Blue Jet Healthcare Limited Competitors by Total Assets
Key competitors of Blue Jet Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Argen-X
F:1AE
|
Germany | €8.68 Billion |
|
CSL Ltd
AU:CSL
|
Australia | AU$39.54 Billion |
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
USA | $398.69 Million |
|
HLB Co. Ltd
KQ:028300
|
Korea | ₩703.48 Billion |
|
SOLENO THERAPEUT. DL-001
F:6XC
|
Germany | €563.83 Million |
|
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
|
USA | $452.70 Million |
|
Tourmaline Bio Inc.
NASDAQ:TRML
|
USA | $269.30 Million |
|
PharmaResources (Shanghai) Co. Ltd. A
SHE:301230
|
China | CN¥1.32 Billion |
Blue Jet Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.21 | 3.93 | 3.40 |
| Quick Ratio | 3.38 | 2.90 | 2.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs7.30 Billion | Rs7.50 Billion | Rs3.96 Billion |
Blue Jet Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Blue Jet Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.07 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 15.8% |
| Total Assets | Rs16.41 Billion |
| Market Capitalization | $957.49 Million USD |
Valuation Analysis
Below Book Valuation: The market values Blue Jet Healthcare Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Blue Jet Healthcare Limited's assets grew by 15.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Blue Jet Healthcare Limited (2020–2026)
The table below shows the annual total assets of Blue Jet Healthcare Limited from 2020 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs16.41 Billion ≈ $177.49 Million |
+15.78% |
| 2025-03-31 | Rs14.18 Billion ≈ $153.30 Million |
+33.87% |
| 2024-03-31 | Rs10.59 Billion ≈ $114.51 Million |
+22.83% |
| 2023-03-31 | Rs8.62 Billion ≈ $93.23 Million |
+20.84% |
| 2022-03-31 | Rs7.13 Billion ≈ $77.15 Million |
+33.02% |
| 2021-03-31 | Rs5.36 Billion ≈ $58.00 Million |
+42.86% |
| 2020-03-31 | Rs3.75 Billion ≈ $40.60 Million |
-- |
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more